5 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
Follow Glomerulosclerosis, Focal Segmental: new trials by email Literature Review of Glomerulosclerosis, Focal Segmental trials Research Report on Glomerulosclerosis, Focal Segmental
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) VB119 - Minimal Change Disease, Focal Segmental Glomerulosclerosis | Phase 2 | Terminated | Tenet Medicines | 1 | 2022-05-03 | 2024-04-22 |
| A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease GFB-887, Placebo - Kidney Diseases, Diabetic Nephropathies | Phase 2 | Terminated | Goldfinch Bio, Inc. | 96 | 2020-07-28 | 2022-11-15 |
| A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) PF-06730512 - Focal Segmental Glomerulosclerosis (FSGS) | Phase 2 | Terminated | Pfizer | 47 | 2018-10-15 | 2024-04-18 |
| A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome CCX140-B - Focal Segmental Glomerulosclerosis | Phase 2 | Terminated | Amgen | 5 | 2018-10-01 | 2025-03-17 |
| Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis Voclosporin - Focal Segmental Glomerulosclerosis | Phase 2 | Terminated | Aurinia Pharmaceuticals Inc. | 5 | 2018-06-21 | 2021-09-16 |
Nephrosis, Lipoid (2) · Proteinuria (2) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Nephropathies (1) · Endocrine System Diseases (1) · Glomerulonephritis (1) · Kidney Diseases (1) · Nephritis (1) · Nephrosis (1) · Urologic Diseases (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Male Urogenital Diseases (5) · Urogenital Diseases (5) · Glomerulonephritis (4) · Kidney Diseases (4) · Nephritis (4) · Urologic Diseases (4) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urination Disorders (2) · Urological Manifestations (2) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nephrosis (1)
CCX140-B (1) · PF-06730512 (1) · voclosporin (1)
Amgen (1) · Aurinia Pharmaceuticals Inc. (1) · Goldfinch Bio, Inc. (1) · Pfizer (1) · Tenet Medicines (1)
United States (5) · Canada (1) · Czechia (1) · Dominican Republic (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Mexico (1) · Poland (1) · Slovakia (1) · Spain (1) · United Kingdom (1)
2019 (1)